A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn

Many patients, after artificial valve replacement surgery, receive warfarin anticoagulant therapy. However, it has been reported that warfarin administration during pregnancy can cause fetal teratogenicity. With reference to this case, we will discuss how warfarin administration in mid-pregnancy cau...

Full description

Saved in:
Bibliographic Details
Main Authors: Hidetake Kamei, Yu Wakimoto, Yumi Murakami, Maya Omote, Kayoko Harada, Atsushi Fukui, Hiroyuki Tanaka, Hideaki Sawai, Hiroaki Shibahara
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Case Reports in Obstetrics and Gynecology
Online Access:http://dx.doi.org/10.1155/2018/6154382
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850212375063429120
author Hidetake Kamei
Yu Wakimoto
Yumi Murakami
Maya Omote
Kayoko Harada
Atsushi Fukui
Hiroyuki Tanaka
Hideaki Sawai
Hiroaki Shibahara
author_facet Hidetake Kamei
Yu Wakimoto
Yumi Murakami
Maya Omote
Kayoko Harada
Atsushi Fukui
Hiroyuki Tanaka
Hideaki Sawai
Hiroaki Shibahara
author_sort Hidetake Kamei
collection DOAJ
description Many patients, after artificial valve replacement surgery, receive warfarin anticoagulant therapy. However, it has been reported that warfarin administration during pregnancy can cause fetal teratogenicity. With reference to this case, we will discuss how warfarin administration in mid-pregnancy caused severe cerebral hemorrhage in the newborn child. The 36-year-old patient in this case underwent aortic valve replacement surgery when she was 11 years old; this requires the continued use of warfarin after surgery. Although she was advised otherwise, the patient became pregnant. The warfarin treatment was discontinued at 5 weeks of gestation and she began self-injection of heparin; however, her health quickly deteriorated requiring an emergency, warfarin treatment. On gestation week 21, she was admitted to our hospital with a high likelihood of a spontaneous abortion. A week later, transesophageal ultrasonography revealed a thrombus in the patient’s aortic valve. Because of this finding, we re-started warfarin administration. At 32 weeks of gestation, cardiotocography showed decreased fetal heart rate; thus, an emergency Cesarean section was performed. A baby was delivered, weighing 1,702 g with an Apgar Score of 1 at 1 minute and 4 at 5 minutes. Cranial computed tomography of the infant showed bilateral intraventricular hemorrhage and ventricular dilation. In order to protect the mother and prevent hemorrhage in the newborn, it is recommended that a continuous heparin infusion should be administered to the pregnant woman after the 36th week of gestation. Regarding the impact on the infant, it is considered that continuous intravenous administration of heparin is safer during the third trimester of pregnancy. However, administration of heparin alone makes the preventive effect of thrombosis uncertain. When warfarin is administered in pregnancy, pregnancy management should be performed bearing the risk of fetal cerebral hemorrhage in mind.
format Article
id doaj-art-8ea01d69e7d1429889b01d32e3cf72cd
institution OA Journals
issn 2090-6684
2090-6692
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Case Reports in Obstetrics and Gynecology
spelling doaj-art-8ea01d69e7d1429889b01d32e3cf72cd2025-08-20T02:09:21ZengWileyCase Reports in Obstetrics and Gynecology2090-66842090-66922018-01-01201810.1155/2018/61543826154382A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the NewbornHidetake Kamei0Yu Wakimoto1Yumi Murakami2Maya Omote3Kayoko Harada4Atsushi Fukui5Hiroyuki Tanaka6Hideaki Sawai7Hiroaki Shibahara8Department of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanDepartment of Obstetrics and Gynecology, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya, Hyogo 663-8501, JapanMany patients, after artificial valve replacement surgery, receive warfarin anticoagulant therapy. However, it has been reported that warfarin administration during pregnancy can cause fetal teratogenicity. With reference to this case, we will discuss how warfarin administration in mid-pregnancy caused severe cerebral hemorrhage in the newborn child. The 36-year-old patient in this case underwent aortic valve replacement surgery when she was 11 years old; this requires the continued use of warfarin after surgery. Although she was advised otherwise, the patient became pregnant. The warfarin treatment was discontinued at 5 weeks of gestation and she began self-injection of heparin; however, her health quickly deteriorated requiring an emergency, warfarin treatment. On gestation week 21, she was admitted to our hospital with a high likelihood of a spontaneous abortion. A week later, transesophageal ultrasonography revealed a thrombus in the patient’s aortic valve. Because of this finding, we re-started warfarin administration. At 32 weeks of gestation, cardiotocography showed decreased fetal heart rate; thus, an emergency Cesarean section was performed. A baby was delivered, weighing 1,702 g with an Apgar Score of 1 at 1 minute and 4 at 5 minutes. Cranial computed tomography of the infant showed bilateral intraventricular hemorrhage and ventricular dilation. In order to protect the mother and prevent hemorrhage in the newborn, it is recommended that a continuous heparin infusion should be administered to the pregnant woman after the 36th week of gestation. Regarding the impact on the infant, it is considered that continuous intravenous administration of heparin is safer during the third trimester of pregnancy. However, administration of heparin alone makes the preventive effect of thrombosis uncertain. When warfarin is administered in pregnancy, pregnancy management should be performed bearing the risk of fetal cerebral hemorrhage in mind.http://dx.doi.org/10.1155/2018/6154382
spellingShingle Hidetake Kamei
Yu Wakimoto
Yumi Murakami
Maya Omote
Kayoko Harada
Atsushi Fukui
Hiroyuki Tanaka
Hideaki Sawai
Hiroaki Shibahara
A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
Case Reports in Obstetrics and Gynecology
title A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
title_full A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
title_fullStr A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
title_full_unstemmed A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
title_short A Case of a Pregnant Woman with Thrombosis in an Artificial Aortic Valve Resulting in Severe Cerebral Hemorrhage in the Newborn
title_sort case of a pregnant woman with thrombosis in an artificial aortic valve resulting in severe cerebral hemorrhage in the newborn
url http://dx.doi.org/10.1155/2018/6154382
work_keys_str_mv AT hidetakekamei acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT yuwakimoto acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT yumimurakami acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT mayaomote acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT kayokoharada acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT atsushifukui acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hiroyukitanaka acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hideakisawai acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hiroakishibahara acaseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hidetakekamei caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT yuwakimoto caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT yumimurakami caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT mayaomote caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT kayokoharada caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT atsushifukui caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hiroyukitanaka caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hideakisawai caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn
AT hiroakishibahara caseofapregnantwomanwiththrombosisinanartificialaorticvalveresultinginseverecerebralhemorrhageinthenewborn